-+ 0.00%
-+ 0.00%
-+ 0.00%

BrainStorm Cell Therapeutics Names Peter J. Pitts Executive Chairman

PUBT·11/16/2026 21:02:02
Listen to the news
BrainStorm Cell Therapeutics Names Peter J. Pitts Executive Chairman
  • BrainStorm Cell Therapeutics appointed Peter J. Pitts executive chairman and chief strategic regulatory and policy officer on July 28, 2026.
  • Pitts, a former FDA associate commissioner, co-founded the Center for Medicine in the Public Interest and joined the board in May 2026.
  • Jacob Frenkel, board chairman since 2020 and a leadership team member since 2007, transitioned to senior adviser.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainstorm Cell Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611161601PR_NEWS_USPR_____LN98797) on November 16, 2026, and is solely responsible for the information contained therein.